JPH10231292A5 - - Google Patents

Info

Publication number
JPH10231292A5
JPH10231292A5 JP1997278908A JP27890897A JPH10231292A5 JP H10231292 A5 JPH10231292 A5 JP H10231292A5 JP 1997278908 A JP1997278908 A JP 1997278908A JP 27890897 A JP27890897 A JP 27890897A JP H10231292 A5 JPH10231292 A5 JP H10231292A5
Authority
JP
Japan
Prior art keywords
phenoxy
piperidinyl
hydroxyphenyl
hydroxynaphthalene
ethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1997278908A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10231292A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH10231292A publication Critical patent/JPH10231292A/ja
Publication of JPH10231292A5 publication Critical patent/JPH10231292A5/ja
Withdrawn legal-status Critical Current

Links

JP9278908A 1996-10-10 1997-10-13 ２−アリール−３−アミノアリールオキシナフチル化合物、中間体、組成物及び方法 Withdrawn JPH10231292A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2844196P 1996-10-10 1996-10-10
US60/028441 1996-10-10

Publications (2)

Publication Number Publication Date
JPH10231292A JPH10231292A (ja) 1998-09-02
JPH10231292A5 true JPH10231292A5 (2) 2005-06-16

Family

ID=21843469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9278908A Withdrawn JPH10231292A (ja) 1996-10-10 1997-10-13 ２−アリール−３−アミノアリールオキシナフチル化合物、中間体、組成物及び方法

Country Status (8)

Country Link
EP (1) EP0835868B1 (2)
JP (1) JPH10231292A (2)
AT (1) ATE204868T1 (2)
CA (1) CA2217810A1 (2)
DE (1) DE69706386T2 (2)
DK (1) DK0835868T3 (2)
ES (1) ES2161417T3 (2)
PT (1) PT835868E (2)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0826679T1 (en) * 1996-08-29 2002-04-30 Eli Lilly And Company Naphthyl compounds and compositions
ID19392A (id) 1996-08-29 1998-07-09 Lilly Co Eli Senyawa naftil dan bahan pertengahan serta komposisi dan metode penggunaan
CA2287244A1 (en) * 1997-04-25 1998-11-05 Henry Uhlman Bryant Indene compounds having activity as serms
EP1169043A1 (en) * 1999-01-18 2002-01-09 Novo Nordisk A/S Use of estrogens and delta-gonadien-21-ol-3,20-diones
KR20020026561A (ko) * 1999-08-03 2002-04-10 존 헤덴스트룀 압축 가능한 컨테이너 및 컨테이너 제조 방법과, 액체수용 컨테이너와, 액체 분출 방법 및 장치와, 키트 또는조합체
AU7896100A (en) * 1999-10-14 2001-04-23 Endorecherche Inc. Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
CA2448235A1 (en) * 2001-07-31 2003-02-13 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
DE60327931D1 (de) * 2002-07-22 2009-07-23 Lilly Co Eli Selektive östrogenrezeptor modulatoren, die eine phenylsulfonyl-gruppe enthalten
KR100693242B1 (ko) * 2003-02-25 2007-03-12 일라이 릴리 앤드 캄파니 결정성 비-용매화1-(4-(2-피페리디닐에톡시)페녹시)-2-(4-메탄술포닐페닐)-6-하이드록시나프탈렌 하이드로클로라이드
CN1910167B (zh) * 2004-01-22 2011-08-10 伊莱利利公司 用于治疗血管舒缩症状的选择性雌激素受体调节剂
AU2005207821B2 (en) * 2004-01-22 2011-02-10 Eli Lilly And Company Selective estrogen receptor modulators for the treatment of vasomotor symptoms
CA2571309A1 (en) * 2004-06-22 2006-01-05 Smithkline Beecham Corporation Chemical compounds
FR2913017A1 (fr) * 2007-02-23 2008-08-29 Cerep Sa Derives de piperidine et piperazine comme agents anti-neoplasiques ou inhibiteurs de proliferation cellulaire
CN114133336B (zh) * 2020-09-03 2024-04-02 沈阳药科大学 4-甲氧基萘取代的苯胺类化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998401A (en) * 1995-02-28 1999-12-07 Eli Lilly And Company Naphthyl compounds, intermediates, compositions, and methods
US5811421A (en) * 1995-07-31 1998-09-22 Eli Lilly And Company Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods

Similar Documents

Publication Publication Date Title
FI117373B (fi) Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti
JP2002513793A5 (2)
CN101416949A (zh) 雌激素药物药用组合物
US4929605A (en) Pharmaceutical composition for piperidinoalkanol derivatives
WO2009042809A1 (en) Stable imatinib compositions
CA2253453A1 (en) Alkylaminobenzothiazole and -benzoxazole derivatives
US4159335A (en) Substituted anilino-2-thiazolines
TW467913B (en) Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt and its preparation
US6514529B2 (en) Oxazolidinone tablet formulation
JPH1087577A5 (2)
US4379155A (en) 3,5-Disubstituted-1H-1,2,4-triazole derivatives
EP0500851A1 (en) PROCESS FOR THE PREPARATION OF A COMPOSITION IN THE FORM OF A TABLET OR DRAGEE COMPRISING AN ACTIVE THERMOSENSITIVE, PHOTOSENSITIVE AND MOISTURE SENSITIVE INGREDIENT HAVING A MONOCLINIC CRYSTAL STRUCTURE.
EP1265608B1 (en) Oxazolidinone tablet formulation
CA2576067A1 (en) Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
US20080234323A1 (en) Amorphous and Three Crystalline Forms of Rimonabant Hydrochloride
WO2023107980A1 (en) Solid state forms of an fgfr inhibitor
CA1316458C (en) Pharmaceutical composition for piperidinoalkanol derivatives
JPH1095778A5 (2)
CA2077122A1 (en) Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same
AU2001243243A1 (en) Oxazolidinone tablet formulation
US20040180937A1 (en) Composition comprising 5-[4-[2-(N-methyl-N-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
US3789125A (en) Pharmaceutical compositions containing halo-substituted 2-amino-benzylamine-amides
AU756338B2 (en) Stabile compositions comprising levosimendan and alginic acid
RU2001124835A (ru) Новые производные морфолина, способ их получения и содержащие их фармацевтические композиции
CY1499A (en) Pharmaceutical preparation comprising co-dergocrine and a calcium antagonist